News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Professor Raymond Schinazi Joins Board Of reViral As Non-Executive Director


4/15/2014 6:18:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LONDON, Apr 15, 2014 (PR Newswire Europe via COMTEX) -- LONDON, April 15, 2014 /PRNewswire/ --

reViral, an antiviral drug discovery and development company, focused on diseases caused by the respiratory syncytial virus (RSV), today announced the appointment of Professor Raymond Schinazi to its Board as a Non-Executive Director, effective from 9 April 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at Market Watch

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES